News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Earnings
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
PrimeEnergy (NASDAQ:PNRG) reported its quarterly earnings, posting an EPS of $2.75, significantly missing the consensus estimate of $5.90 by $3.15. Despite the earnings miss, the stock saw a slight increase of $5.39 to $200.98 on Friday, though trading volume was below average. Analyst sentiment …
PrimeEnergy Resources (NASDAQ: PNRG) reported a Q2 2026 net income of $6.5 million, up from $3.2 million in the prior year, despite its first-half net income declining to $10.9 million from $12.4 million in 2025. The company benefited from a strong average realized oil …
Kayne Anderson Rudnick Investment Management, LLC has reported a beneficial ownership of 2,768,786 shares in Primerica, Inc., representing 8.9% of the company's common stock as of June 30, 2026. This filing indicates that Kayne Anderson Rudnick is a significant institutional shareholder, possessing both sole …
HC Wainwright has revised its Q3 2026 EPS estimate for Prime Medicine (NASDAQ: PRME) to a loss of $0.28 per share, a slight improvement from the previous forecast of $0.29. Despite maintaining a "Buy" rating and an $8.00 price target, analysts still anticipate the …
Primerica Inc (PRI) Director Amber Cottle sold 279 shares of the company stock, valued at approximately $87,503. This sale aligns with a broader trend of insider selling at Primerica over the past year, with 12 insider sells and no buys. Despite the selling activity, …
KBW has increased its target price for Primerica, Inc. (PRI) to $335 from $323. This update was reported by Reuters on August 11, 2026. The article itself is a brief announcement without further details on the rationale behind the target price adjustment.
This article reports on an SEC Form 144 filing by Primerica, Inc. (PRI) on August 11, 2026. The filing indicates a proposed sale of 279 common shares acquired from equity plans, with an aggregate market value of $87,502.43. The document also details the acquisition …
Keefe, Bruyette & Woods increased its price target for Primerica (NYSE:PRI) to $335 from $323, maintaining a "market perform" rating and suggesting a 6.88% upside. Despite the positive outlook from Keefe, Bruyette & Woods, overall analyst sentiment for Primerica is "Hold" with an average …
Ausbil Investment Management Ltd significantly increased its stake in Primerica, Inc. (NYSE:PRI) by 166.8% in the second quarter, acquiring an additional 5,170 shares and bringing its total holdings to 8,269 shares valued at $2.41 million. Primerica reported strong quarterly earnings, surpassing estimates with an …
Vista Investment Partners LLC significantly increased its stake in Primerica, Inc. (NYSE:PRI) by 41.8% in Q2, bringing their total holdings to 15,412 shares valued at $4.38 million. Institutional investors collectively own a substantial 90.88% of Primerica. The company recently reported strong quarterly earnings, beating …
H.C. Wainwright has reiterated its Buy rating for Prime Medicine (PRME.US) and maintained its target price at $8. This indicates a continued positive outlook from the firm regarding Prime Medicine's stock performance.
Primerica (PRI) CEO Glenn Williams sold 1,500 shares of the company's stock for approximately $480,300, bringing his direct ownership to 32,195.995 shares. This sale is part of a consistent pattern of insider selling at Primerica over the past year, with no insider buys. GuruFocus …
Primerica (PRI) executive Glenn J. Williams has filed a Form 144 to sell 1,500 shares of common stock, valued at $482,070.00, through Morgan Stanley Smith Barney LLC. These shares originate from Restricted Stock Units granted on March 1, 2026. The filing also disclosed a …
A Primerica insider recently sold shares valued at $480,300, as reported in a recent SEC filing. The article highlights this transaction along with other recent news concerning Primerica, including its Q2 2026 earnings call, adjusted earnings, revenue rise, and dividend approval. It also provides …
Renaissance Technologies LLC has reduced its stake in Prime Medicine, Inc. (NASDAQ:PRME) by 35.5%, selling 408,120 shares but still retaining 741,039 shares valued at approximately $2.58 million. This comes as Prime Medicine reported a quarterly loss of $0.24 per share, meeting analyst estimates, yet …
Jefferies has increased its target price for Primerica, Inc. to $276 from $268. This update reflects an analyst's revised valuation for the company. The article, sourced from Reuters, serves as a financial news brief.
Primerica (PRI) reported strong Q2 results, primarily driven by its investment and savings products (ISP) segment, which saw significant revenue and operating income growth. While life insurance sales faced pressure due to economic uncertainty among middle-income households, the company is implementing strategies to improve …
Primerica, Inc. reported strong Q2 2026 results with increased revenue and net income, alongside affirming a dividend and completing significant share repurchases. While the earnings beat and capital returns support its investment narrative, investors are advised to consider risks like falling life insurance policy …
This article provides an earnings forecast for Primech Holdings Ltd (PMEC), focusing on future EPS and revenue growth estimates. It includes current stock information, market capitalization, and a peer comparison for PMEC, which is categorized under Professional & Commercial Services. The data was last …
Search by ticker symbol or company name and select a result to open its chart.